The Global Burden of Disease Study (GBD) is a comprehensive regional and global research program of disease burden that assesses mortality and disability from major diseases, injuries, and risk factors. GBD is a collaboration of over 3600 researchers from 145 countries. Under principal investigator Christopher J.L. Murray, GBD is based in the Institute for Health Metrics and Evaluation (IHME) at the University of Washington and funded by the Bill and Melinda Gates Foundation.
Global Life Expectancy To Increase By Nearly 5 Years By 2050 Despite Geopolitical, Metabolic, And Environmental Threats
The latest findings from the Global Burden of Disease Study (GBD) 2021, published in The Lancet, forecast that global life..
Eurasia Review